---
figid: PMC4754913__13045_2016_236_Fig2_HTML
figlink: /pmc/articles/PMC4754913/figure/Fig2/
number: F2
caption: Diagram summarizing the reviewed mechanisms by which CCR9 induces different
  aspects of tumor chemoresistance. The interaction of CCL25/CCR9 can induce tumor
  chemoresistance via the PI3K-AKT-(GSK-3β/mTOR/NF-κB/β-catenin) and JAK-STAT pathways.
  The interactions between P-gp, ERM, and F-actin can induce tumor chemoresistance
  via the CCL25/CCR9 pathway
pmcid: PMC4754913
papertitle: 'CCR9 in cancer: oncogenic role and therapeutic targeting.'
reftext: Zhenbo Tu, et al. J Hematol Oncol. 2016;9:10.
pmc_ranked_result_index: '110132'
pathway_score: 0.9581488
filename: 13045_2016_236_Fig2_HTML.jpg
figtitle: Diagram summarizing the reviewed mechanisms by which CCR9 induces different
  aspects of tumor chemoresistance
year: '2016'
organisms:
- Homo sapiens
ndex: 9ff16ab8-dee4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4754913__13045_2016_236_Fig2_HTML.html
  '@type': Dataset
  description: Diagram summarizing the reviewed mechanisms by which CCR9 induces different
    aspects of tumor chemoresistance. The interaction of CCL25/CCR9 can induce tumor
    chemoresistance via the PI3K-AKT-(GSK-3β/mTOR/NF-κB/β-catenin) and JAK-STAT pathways.
    The interactions between P-gp, ERM, and F-actin can induce tumor chemoresistance
    via the CCL25/CCR9 pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTEN
  - STAT5B
  - AKT1
  - AKT2
  - CTNNB1
  - AKT3
  - TYK2
  - ABCB1
  - STAT6
  - MTOR
  - STAT3
  - JAK3
  - JAK1
  - STAT1
  - STAT2
  - NFKB1
  - STAT5A
  - RORC
  - JAK2
  - CCR9
  - STAT4
genes:
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: p-gp
  symbol: P-gp
  source: hgnc_alias_symbol
  hgnc_symbol: ABCB1
  entrez: '5243'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: CCR9
  symbol: CCR9
  source: hgnc_symbol
  hgnc_symbol: CCR9
  entrez: '10803'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
chemicals: []
diseases: []
figid_alias: PMC4754913__F2
redirect_from: /figures/PMC4754913__F2
figtype: Figure
---
